Aurobindo Pharma Limited is a leading multinational pharmaceutical company specializing in generic medicines, active pharmaceutical ingredients, injectable products, biosimilars, and specialty pharmaceuticals. Established in 1986, the company has grown into one of India’s largest pharmaceutical exporters, supplying medicines to more than 150 countries. Aurobindo has built strong capabilities across antibiotics, antivirals, cardiovascular, central nervous system, gastroenterology, oncology, and hormonal therapies. The company operates an extensive global manufacturing network supported by vertically integrated API production, enabling cost-efficient and high-quality pharmaceutical manufacturing. Its facilities comply with stringent international regulatory standards, including approvals from the US FDA, EMA, and other major health authorities. Aurobindo continues to expand its specialty and biosimilar businesses while investing in research, product development, and manufacturing excellence. With a diversified product portfolio and strong international presence, the company remains a key contributor to affordable healthcare worldwide.
NSE: AUROPHARMA | BSE: 524804
Hyderabad, Telangana, India
~29,000 employees
